In the SURPASS-2 trial (published in The New England Journal of Medicine in 2021), tirzepatide at 5, 10, and 15 mg was compared with semaglutide 1 mg in 1,879 adults with type 2 diabetes on metformin over 40 weeks
This leads to frequent questions such as does tirzepatide show up on blood test , how long has tirzepatide been around , and tirzepatide nhs regulatory interest
The raw numbers favor retatrutide
The rise of AI-powered healthcare platforms is transforming how patients manage chronic conditions and medication side effects
While not listed as a direct adverse effect in FDA prescribing information, this cold sensitivity appears linked to the medication's weight loss effects rather than direct temperature regulation changes
doi: 10.1677/jme.0.0100259 44 GallwitzBWittMPaetzoldGMorys-WortmannCZimmermannBEckartKet al